| 1 |
34392748 | The role of dipeptidyl peptidase-IV in abdominal aortic aneurysm pathogenesis: A systematic review. | 2022 Feb |
1 |
| 2 |
35367243 | ZD-2, a novel DPP4 inhibitor, protects islet β-cell and improves glycemic control in high-fat-diet-induced obese mice. | 2022 Jun 1 |
2 |
| 3 |
35468904 | The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment. | 2022 Apr 25 |
1 |
| 4 |
33073318 | DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism. | 2021 Jan |
2 |
| 5 |
33310040 | Vildagliptin, a dipeptidyl peptidase-4 inhibitor, reduces betel-nut induced carcinogenesis in female mice. | 2021 Feb 1 |
2 |
| 6 |
33894269 | CD26 as a target against fibrous formation in chronic airway rejection lesions. | 2021 Aug 1 |
1 |
| 7 |
31350829 | Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis. | 2020 Jan |
1 |
| 8 |
30698677 | The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity. | 2019 Apr 29 |
6 |
| 9 |
31735774 | Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice. | 2019 Nov 30 |
1 |
| 10 |
29031704 | Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia. | 2018 Jan |
1 |
| 11 |
29145151 | Vildagliptin loaded triangular DNA nanospheres coated with eudragit for oral delivery and better glycemic control in type 2 diabetes mellitus. | 2018 Jan |
1 |
| 12 |
29154902 | Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice. | 2018 Mar |
4 |
| 13 |
29797022 | The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice. | 2018 Aug |
2 |
| 14 |
27895112 | Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo. | 2017 Feb |
4 |
| 15 |
27939504 | Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin. | 2017 Mar |
5 |
| 16 |
28526921 | GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice. | 2017 Aug |
1 |
| 17 |
29037205 | Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. | 2017 Oct 16 |
2 |
| 18 |
26603140 | The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes. | 2016 Feb |
2 |
| 19 |
26773932 | Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate. | 2016 Feb |
2 |
| 20 |
25195070 | Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice. | 2015 Feb |
1 |
| 21 |
26091000 | Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity. | 2015 |
1 |
| 22 |
26233333 | Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice. | 2015 Oct |
4 |
| 23 |
24939431 | Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes. | 2014 Sep |
1 |
| 24 |
25100725 | Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism. | 2014 Sep 26 |
1 |
| 25 |
23636640 | Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model. | 2013 Aug |
3 |
| 26 |
23669105 | Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. | 2013 Oct 9 |
1 |
| 27 |
23967137 | Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice. | 2013 |
1 |
| 28 |
24103756 | Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice. | 2013 Nov 1 |
1 |
| 29 |
22219460 | CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. | 2012 May |
2 |
| 30 |
22315446 | Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet. | 2012 Mar |
1 |
| 31 |
22819773 | Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression. | 2012 Sep |
1 |
| 32 |
22822047 | DPP4 inhibitor vildagliptin preserves β-cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice. | 2012 Oct |
2 |
| 33 |
17482289 | DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide. | 2007 Oct 4 |
1 |
| 34 |
16171801 | Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice. | 2005 Oct 3 |
1 |